Search Within

Christopher A Famulare

Formats
  1. Meeting Abstract (49)
  2. Journal Article (32)
  3. Research Letter (7)
Groups
  1. Center for Hematologic Malignancies (88)
  2. Department of Medicine (85)
  3. Hematologic Malignancies, Division of (85)
  4. Adult Leukemia (83)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (56)
  6. GSK Faculty (56)

More Groups

People
  1. Ross Levine (48)
  2. Martin Tallman (39)
  3. Aaron Goldberg (37)
  4. Eytan Stein (30)
  5. Mikhail Roshal (28)
  6. Minal Patel (27)

More People

Years
  1. 2025 (5)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (11)
  6. 2020 (14)

More Years

Publications
  1. Blood (49)
  2. Blood Advances (6)
  3. American Journal of Hematology (4)
  4. Cancer Discovery (4)
  5. Leukemia and Lymphoma (3)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (5)
  4. John Wiley & Sons, Inc. (4)
  5. Taylor & Francis Group (3)
  6. Cell Press (2)

More Publishers

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia
    Meeting Abstract

    Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Landscape of TP53 mutations in MPN
    Meeting Abstract

    Farnoud, N.; Famulare, C.; Papaemmanuil, E.; McGovern, E.; Medina, J.; Arango Ossa, J. E.; Rampal, R. K.; Li, B.; Levine, R. L.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Combined venetoclax and hypomethylating agent (HMA) therapy induces high response rates in patients with myelodysplastic syndrome including patients previously failing HMA
    Meeting Abstract

    Ball, B. J.; Famulare, C.; Stein, E. M.; Tallman, M. S.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; Testi, R.; Al Ali, N.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Single cell DNA sequencing identifies combinatorial mutation patterns and clonal architecture in myeloid malignancies
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Merlinsky, T. R.; Ooi, A.; Mendez, P.; Famulare, C.; Patel, M. A.; Bolton, K.; Palmisiano, N.; Carroll, M. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Overcoming adaptive therapy resistance in AML by targeting immune response pathways
    Journal Article

    Melgar, K.; Walker, M. M.; Jones, L. M.; Bolanos, L. C.; Hueneman, K.; Wunderlich, M.; Jiang, J. K.; Wilson, K. M.; Zhang, X.; Sutter, P.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save